[MO18] Mini-Oral Session 18　乳腺1（薬物療法・サバイバーシップ）
【E】

[MO18-2] A phase II trial of neoadjuvant apatinib combined with nab-paclitaxel and carboplatin in triple-negative breast cancer

^○Tianyu Zeng¹, Jue Wang², Wei Li¹, Chunxiao Sun¹, Fan Yang¹, Yan Liang¹, Ziyi Fu¹, Xiaoming Zha², Yongmei Yin¹ (1.Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, 2.Department of Breast Disease, the First Affiliated Hospital of Nanjing Medical University)